<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35999107</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2623</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Transplantation proceedings</Title><ISOAbbreviation>Transplant Proc</ISOAbbreviation></Journal><ArticleTitle>Outcomes Associated With COVID-19 Hospitalization in Heart Transplantation Patients.</ArticleTitle><Pagination><StartPage>2688</StartPage><EndPage>2691</EndPage><MedlinePgn>2688-2691</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.transproceed.2022.06.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0041-1345(22)00453-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Heart transplantation (HT) recipients infected with COVID-19 may be at an increased risk of severe illness due to chronic immunosuppression.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Adult HT patients hospitalized with COVID-19 at the Cleveland Clinic between March 2020 and March 2021 were included in this retrospective cohort analysis. Twenty-four HT cases were matched to 96 non-HT controls, similarly hospitalized with COVID-19, out of 11,481 patients based on different baseline characteristics. Primary outcome was all-cause mortality; secondary outcomes included mechanical ventilation, intensive care unit admission, vasopressor need, dialysis, pneumonia, and 90-day readmission. Subgroup analysis was performed based on the time from transplantation (within 1 year of transplantation and greater than 1 year since transplantation).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Both primary and secondary outcomes were not significant. Subgroup analysis did not show a significant difference in mortality (P&#xa0;=&#xa0;.355) or 30-day readmission (P&#xa0;=&#xa0;.841) between patients who were within 1 year of transplantation and remote transplantation beyond 1 year. Univariable analysis of immunosuppressant continuation, dose-reduction, or discontinuation did not significantly affect HT mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Despite limited sample size, our results suggest that HT patients do not show worse outcomes after acquiring COVID-19, whether in the first year of transplantation or after a remote transplantation procedure. Future studies with multicenter data that incorporate the subsequent COVID-19 variants (eg, Delta and Omicron), the impact of long COVID-19, and assessing full vs reduced immunosuppression regimens would add insights to this patient population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kanaan</LastName><ForeName>Christopher N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iskandar</LastName><ForeName>Jean-Pierre</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gad</LastName><ForeName>Mohamed M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondoleon</LastName><ForeName>Nicholas P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirzai</LastName><ForeName>Saeid</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsich</LastName><ForeName>Eileen M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Kaufman Center for Heart Failure, Department of Cardiology, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Estep</LastName><ForeName>Jerry D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Kaufman Center for Heart Failure, Department of Cardiology, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fares</LastName><ForeName>Maan A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio. Electronic address: faresm@ccf.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL141892</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transplant Proc</MedlineTA><NlmUniqueID>0243532</NlmUniqueID><ISSNLinking>0041-1345</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016027" MajorTopicYN="Y">Heart Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>23</Day><Hour>22</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35999107</ArticleId><ArticleId IdType="pmc">PMC9212532</ArticleId><ArticleId IdType="doi">10.1016/j.transproceed.2022.06.002</ArticleId><ArticleId IdType="pii">S0041-1345(22)00453-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chaudhry ZS, Williams JD, Vahia A, Fadel R, Parraga Acosta T, Prashar R, et al. Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: a cohort study. Am J Transplant. 2020;20:3051&#x2013;3060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405160</ArticleId><ArticleId IdType="pubmed">32654332</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma P, Chen V, Fung CM, Troost JP, Patel VN, Combs M, et al. COVID-19 outcomes among solid organ transplant recipients: a case-control study. Transplantation. 2021;105:128&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7853506</ArticleId><ArticleId IdType="pubmed">32890139</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottio T, Bagozzi L, Fiocco A, Nadali M, Caraffa R, Bifulco O, et al. COVID-19 in heart transplant recipients: A multicenter analysis of the Northern Italian outbreak. JACC Heart Fail. 2021;9:52&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7604081</ArticleId><ArticleId IdType="pubmed">33309578</ArticleId></ArticleIdList></Reference><Reference><Citation>Latif F, Farr MA, Clerkin KJ, Habal MV, Takeda K, Naka Y, et al. Characteristics and outcomes of recipients of heart transplant with coronavirus disease 2019. JAMA Cardiol. 2020;5:1165&#x2013;1169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7221850</ArticleId><ArticleId IdType="pubmed">32402056</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Cai J, Dong N. First cases of COVID-19 in heart transplantation from. China. J Heart Lung Transplant. 2020;39:496&#x2013;497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7156127</ArticleId><ArticleId IdType="pubmed">32362394</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavarot N, Gueguen J, Bonnet G, Jdidou M, Trimaille A, Burger C, et al. Critical COVID-19 France Investigators. COVID-19 severity in kidney transplant recipients is similar to nontransplant patients with similar comorbidities. Am J Transplant. 2021;21:1285&#x2013;1294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753406</ArticleId><ArticleId IdType="pubmed">33252201</ArticleId></ArticleIdList></Reference><Reference><Citation>Linares L, Cofan F, Diekmann F, Herrera S, Marcos MA, Castel MA, et al. Hospital clinic COVID-19 research group. A propensity score-matched analysis of mortality in solid organ transplant patients with COVID-19 compared to non-solid organ transplant patients. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928439</ArticleId><ArticleId IdType="pubmed">33657157</ArticleId></ArticleIdList></Reference><Reference><Citation>Granger C, Guedeney P, Arnaud C, Guendouz S, Cimadevilla C, Kerneis M, et al. Clinical manifestations and outcomes of coronavirus disease-19 in heart transplant recipients: a multicentre case series with a systematic review and meta-analysis. Transpl Int. 2021;34:721&#x2013;731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014589</ArticleId><ArticleId IdType="pubmed">33539616</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>